Neurodegenerative diseases such as Alzheimer’s and Parkinson’s are a growing global health burden, and there is rising interest in plant-based neuroprotectants. This 2024 review examines the emerging evidence for Moringa oleifera in that role.
The review surveys how moringa — long used in traditional medicine for neurological disorders — may help manage cognitive impairment and neurodegeneration.
Key points
- Moringa is highlighted as an emerging neuroprotectant, with traditional use against Alzheimer’s, Parkinson’s, Huntington’s, epilepsy and neurotoxicity.
- Its significant antioxidant and anti-inflammatory properties underpin this neuroprotective potential.
- The authors call for more research to translate this promise into therapies.
Why it matters for MORIFA: Brain and cognitive health is one of the fastest-growing segments in supplements. A recent peer-reviewed review tying moringa leaf to neuroprotection supports premium positioning for our leaf powder with nutraceutical buyers.
Caveat: a review of largely preclinical evidence; this is research information, not a medical claim or advice.
Summary of: (2024). “An update on the emerging neuroprotective potential of Moringa oleifera.” Phytomedicine Plus, 4, 100532. DOI: 10.1016/j.phyplu.2024.100532. Summarised by MORIFA; full paper via the link above.